Full Press Release Details
BELGRADE, Mont.,Sept. 4, 2025/PRNewswire/ --Xtant Medical Holdings, Inc.(NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that Sean Browne, CEO, and Scott Neils, CFO, will be participating in the H.C. Wainwright 27th Annual Global Investment Conference, which is being heldSeptember 8-10, 2025, inNew Yorkand virtually.
A company presentation will be available on demandhereas ofFriday, September 5at7:00 A.M. (ET). In addition, Xtant's management team will be available for virtual one-on-one meetings onSeptember 8th. Interested investors should contact their representative at H.C. Wainwright. A replay of the presentation will be posted to thePresentation & Eventspage of Xtant's Investors website for 90 days.
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in theUnited States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.